Skip to main content

Table 2 Change in management based on biopsy

From: Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

Reference

Number of patients

Therapy changed (%)

Lindstrom et al. [7]

1,010

23 (HER2) 50 (ER)

Curigliano et al. [9]

255

12.1

Amir et al. [2]

289

14.2

Bogina et al. [11]

140

7.3

Amir et al. [4]

121

14

Simmons et al. [15]

40

20

Thompson et al. [5]

137

17.5

  1. ER, estrogen receptor; HER2, human epidermal growth factor receptor 2.